Description

Ksefocam (Lornoxicam) Powder for Injections 8 mg. №5 Vial

Ingredients:

Each vial contains 8 mg of Lornoxicam as the active ingredient.

Dosage:

The usual dose is 8-16 mg per day, administered via intramuscular or intravenous injection. Dosage may vary based on the condition being treated and the patient’s response.

Indications:

Ksefocam is indicated for the treatment of acute pain, postoperative pain, and inflammatory conditions such as rheumatoid arthritis and osteoarthritis.

Contraindications:

Do not use Ksefocam in patients with a history of hypersensitivity to lornoxicam or other NSAIDs. It is contraindicated in patients with active peptic ulcers and severe renal or hepatic impairment.

Directions:

Administer Ksefocam as directed by a healthcare provider. The injection should be given slowly over 2-3 minutes to reduce the risk of adverse reactions.

Scientific Evidence:

Lornoxicam, the active ingredient in Ksefocam, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. It works by inhibiting the enzyme cyclooxygenase, thereby reducing the production of prostaglandins that are involved in the inflammatory process.

Several studies have demonstrated the efficacy of lornoxicam in the management of pain and inflammation. A study published in the Journal of Pain Research showed that lornoxicam provided effective pain relief in patients with osteoarthritis, with a favorable safety profile.

Additional Information:

• Storage: Store Ksefocam vials at room temperature away from light and moisture.
• Side Effects: Common side effects may include nausea, headache, and dizziness. Serious side effects such as gastrointestinal bleeding or allergic reactions are rare but possible.